As the global nutraceutical industry shifts from chemistry-based standardisation to evidence-backed, energy-aware innovation, Greenspace Herbs is pioneering a new frontier called Quantum Ayurveda. In an exclusive conversation, Shafiulla Nuruddin Hirehal, Director of Greenspace Herbs, shares with Dr. Asawari Savant of Elets News Network (ENN), how the company is fusing physics, AI, and classical Ayurvedic principles to solve one of the industry’s biggest challenges—inconsistent outcomes from natural ingredients—and redefining how India’s botanical science ecosystem can compete globally.

Please share about Greenspace Herbs and what led you to build it.

Greenspace Herbs is a botanical science company advancing Quantum Ayurveda, a physics-first way to design and validate Ayurvedic botanicals using Raman spectroscopy, electron microscopy, Electromagnetic interference, and AI alongside classical principles. In plain terms, we don’t just standardise chemistry; we measure and tune herbs’ energy signatures, then lock that state so the ingredient stays “primed” until it meets the body. 

The core problem we set out to solve is inconsistent outcomes: practitioners know that equal doses of a “standardised” extract don’t always produce equal effects. Variability in plant micro-structure, processing, and the body’s biofield all contribute. Our platform adds a repeatable layer of resonance control and instrument-level verification (e.g., Raman, NMR, EM) so brands and clinicians get dossiers that move beyond “% actives” to how the material behaves. 

I come from industrial engineering and process control, so the company was built with a systems mindset, from sourcing and lab workflow to a six-stage formulation pipeline that ends in IRB-approved pilots and global compliance. 

What happens when AI is integrated with botanicals? How does it work, and does it affect effectiveness?

We use AI in two places:

1. Design & prediction: AI models (including Nutrify Genie engine) analyse spectral fingerprints (Raman/IR) and phytochemistry to predict compatible herb synergies, carrier systems, and target resonance bands for a given outcome (e.g., metabolic or neurovascular). This guides what we build before we run bench or pilot studies. 
2. Process control: During compounding/drying, we apply programmed acoustic and electromagnetic exposures in timed patterns that subtly steer particle microstructure so the powder wets and disperses more readily. We then verify the “imprint” with spectroscopy. In simple terms, the lattice is preloaded with useful potential energy and an identifiable signature. 

Does this affect effectiveness? That’s the goal. By improving dispersion, dissolution, and recognition by the body, the same chemistry can perform more consistently, potentially at lower doses, a hypothesis we test via in-vitro work and IRB-approved human pilots in our pipeline. 

Please talk about the AYUQUANTA 7™ process. How does it address the inconsistency in natural ingredients?

AYUQUANTA 7™ is our seven-part innovation framework that underpins our EASI™ (Energized Active Supplement Ingredients) portfolio—for example, AshwagandhaQA™, CurcuminQA™, BerberineQA™. Each ingredient is developed under AYUQUANTA 7 and Raman-verified for a stable resonance signature. 

While the specific steps are proprietary, the framework typically includes:

• Spectral fingerprinting & AI modelling to define target signatures and compatibilities.
• Resonance loading (field exposures) to “tune” the ingredient.
• Lattice locking to preserve the tuned micro-structure.
• Instrument verification (e.g., Raman) and stability checks.
• Preclinical and pilot-clinical validation to translate into human outcomes.

By combining resonance loading + lattice locking with instrument checks, we reduce batch-to-batch drift that plagues botanicals—moving from “same % actives” to same energy-behaviour profile. 

What are acoustic priming and magnetic & light-field conditioning, and how are they integrated into AYUQUANTA 7?

• Acoustic priming: exposing an extract to programmed sound waves so particles and complexes self-organise toward a preferred micro-structure (think: nudging how crystals form).
• Magnetic and light-field conditioning: brief, controlled electromagnetic and photic exposures during processing that further tune vibrational states and imprint a measurable signature without changing core chemistry.

In AYUQUANTA 7, these steps appear in the resonance loading phase. They’re executed under SOPs (time, frequency, intensity) and then confirmed with spectroscopy (e.g., Raman), so we don’t rely on “belief”, we record the signature. 

Our public demos (e.g., at SupplySide Global) show two visually identical powders, one post-conditioning; spectroscopy distinguishes them, while early lab readouts suggest differences in oxidative and inflammatory pathway modulation, evidence we’re expanding with clinical trials. 

Which botanicals or product categories are prioritised in your R&D?

We prioritise five need states where Ayurveda is strong and global demand is rising:
Women’s hormonal health; cognitive and neurovascular health; pain; gut–liver axis; inflammation, joints, and immune health; metabolic wellness/weight. 

On the ingredient side, current EASI™ actives include AshwagandhaQA™, CurcuminQA™, and BerberineQA™, each developed under AYUQUANTA 7 with resonance verification. Additional “Quantum Generics” and polyherb blends are moving through the pipeline and IRB-approved pilots. 

Also read: Digital Dentistry Market in India 2025: Opportunities, Challenges, and Growth Drivers

What is your 3–5 year growth strategy? Are you pursuing international markets?

Platform first, then portfolio. We’ll scale the EASI™ branded actives, passing them through our six-stage T.R.U.S.T. pipeline, from quantum/phyto-profiling to human studies and global compliance. That keeps our claims evidence-led and retailer-ready. 

Global commercialisation, India-rooted science. Core R&D and manufacturing remain in India, with a U.S. bridge (Piscataway, NJ) for tech-transfer and market access. We’re already on international stages (e.g., SupplySide Global) and engaging partners in North America and Asia. 

Why this matters for India’s value chain. By keeping resonance loading and verification in the country and exporting finished, dossier-ready actives, suppliers move up the ladder—from farm to formula-grade, IP-backed ingredients that travel with documentation global brands recognise. 

Like

Dislike

Be a part of Elets Collaborative Initiatives. Join Us for Upcoming Events and explore business opportunities. Like us on Facebook , connect with us on LinkedIn and follow us on Twitter , Instagram.

"Exciting news! Elets technomedia is now on WhatsApp Channels Subscribe today by clicking the link and stay updated with the latest insights!" Click here!